Navigation Links
Audax Medical, Inc. Secures Exclusive Rights to Novel Osteobiologic Nanotechnology
Date:12/7/2010

LITTLETON, Mass., Dec. 7, 2010 /PRNewswire/ -- Audax Medical, Inc. (www.audaxmed.com), a privately-held medical device company specializing in the development of osteobiologics, has entered into a comprehensive license agreement with Brown University, acquiring exclusive rights to a proprietary osteobiologic nanotechnology. The biomaterial, Arxis™, is being developed for use in multiple clinical applications for the regeneration of diseased bone, cartilage, and other soft tissues.  

An additional research agreement has been completed with the Brown University School of Engineering and Department of Orthopedics to further support clinical development of the technology.

"Our partnership with Brown and the University's world-class scientific team is a significant milestone for Audax Medical," stated Mark A. Johanson, President and Chief Executive Officer.  "The addition of this technology to the company's product portfolio greatly expands our growing regenerative osteobiologics and soft tissue platforms."

Under the terms of the agreement, Audax Medical has obtained exclusive license to a platform of intellectual property and technologies co-developed by Thomas Webster, Brown professor of engineering, addressing the treatment of degenerative bone and soft tissues.

"We are very excited to have partnered with such an experienced and accomplished team at Audax Medical," stated Katherine Gordon, Managing Director of the Brown University Technology Ventures Office. "The scientific and commercial expertise from both the Brown and Audax teams are impressive, offering a significant opportunity for both clinical and commercial success."

The Arxis™ biomaterial consists of organic nanomolecules which have the potential to meet an array of clinical needs. The implantable material can incorporate varying growth agents that allow its end characteristics to be customized for multiple clinical and regenerative indications throughout the musculoskeletal system.

More information about the science behind the technology, including pictures and video, can be found at http://today.brown.edu/articles/2010/11/audax.

About Audax Medical, Inc.

Audax Medical, Inc. is a privately held medical device company located in Littleton, Massachusetts. The company offers innovative solutions for the treatment of degenerative bone and musculoskeletal tissue. The company's products go beyond simply stabilizing a clinical deficiency by promoting the growth of natural bone and tissue. With enhanced surgical based solutions and osteogenic biomaterial technologies, Audax offers a modern alternative to existing orthopedic therapies.  For more information visit, www.audaxmed.com


'/>"/>
SOURCE Audax Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Prescient Medical, Inc. Presenting at the 5th Annual Canaccord Genuity Cardiovascular Conference
2. Cayenne Medical, Inc. Reaches 50,000 Implant Milestone
3. A Platform Technology to Address Bioterrorism Released by Aethlon Medical, Inc.
4. China Medical Technologies Announces its Subsidiary, GP Medical, Ranked Sixth in Deloitte Technology Fast 50 China 2010 Program
5. China Sky One Medical, Inc. Reports Outcome of Annual Meeting of Shareholders
6. Nonin Medical, Inc. Announces Capnography Division Name Change; Expands Swedish Manufacturing Facility to Become Full-Franchise European Sales, Distribution and Service Center
7. CSA Medical, Inc. Announces 75th Customer
8. Len DeBenedictis Retires as Chief Technology Officer of Solta Medical, Inc.
9. BlueDot Medical, Inc. Named to 2010 Inc. 500/5000
10. BINDER BIOMEDICAL, INC. Announces Official Launch of the NEWTON™ Intervertebral Body Fusion Spinal Spacer System
11. Solta Medical, Inc. Announces Second Quarter 2010 Results Release Date and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... April 28, 2016  Marking its one year ... and ovarian cancer risk test, Color Genomics ... genes that highly impact the most common hereditary ... the Color Test analyzes hereditary cancer risks for ... uterine cancers. The Color Test is physician ordered ...
(Date:4/28/2016)... YORK , April 28, 2016 ... online consumer insights on healthcare, announced today that it ... their report Cool Vendor in Life Sciences, 2016, ... April 15, 2016.  The report focuses on life-science- oriented ... gain insight from patients and doctors, confirm medication ingestion, ...
(Date:4/28/2016)... April 28, 2016 Oramed Pharmaceuticals Inc. ... pharmaceutical company focused on the development of oral drug delivery ... upcoming PIONEERS 2016 conference, presented by Joseph Gunnar ... New York . Nadav Kidron , ... conference. Presentation Details:   PIONEERS ...
Breaking Medicine Technology:
(Date:5/2/2016)... ... May 02, 2016 , ... MedaCheck, a leading medication ... outcomes, has announced its partnership with GrandView Health Services. , With decades of ... counter and prescription drug pharmacy services to thousands of residents. Serving Indiana, Ohio, ...
(Date:5/2/2016)... TN (PRWEB) , ... May 02, 2016 , ... ... and behavioral health services, today announced the opening of Twin Lakes Recovery Center. ... will be Summit’s first in the state. The residential facility is set ...
(Date:5/1/2016)... (PRWEB) , ... May 01, 2016 , ... Women's Excellence ... Essential Oils and taught by Patti Dolan, a Young Living Gold Member. , The ... 6:30pm - 7:15pm followed by a small intro to the Oils that can benefit ...
(Date:4/30/2016)... (PRWEB) , ... May 01, 2016 , ... Serenity Recovery, ... to rehabilitation, has produced a new video that focuses on one of the more ... recent sessions and clips from interviews with a participating patients and the Yoga class ...
(Date:4/30/2016)... , ... April 30, 2016 , ... ... Boise, President and CEO of EMED, today signed a multifaceted agreement which will ... and the Northern Caribbean University Department of Natural and Applied Sciences, Allied Health ...
Breaking Medicine News(10 mins):